The Icelandic company was founded in 2014 by Saemundur Oddsson and Tryggvi Thorgeirsson, two passionate medical doctors on a mission to improve the health of humanity. The cornerstone of Sidekick’s approach is our multi-chronic digital therapeutics platform, and this funding will allow us to scale even faster the production of a new generation of clinical treatments across all major chronic diseases.” Viking roots, fighting illness Sidekick’s co-Founder and CEO Dr Tryggvi Thorgeirsson stated in a release, “The major challenge facing the world’s healthcare systems is how to support and treat people who are dealing with two or more chronic conditions. The platform is approved as a CE-marked, Class I Medical Device. So far, Sidekick’s platform is assisting global customers like Pfizer and Bayer to develop integrated combination therapeutics consisting of molecular drugs and digital therapeutics. The platform also combines an evidence-based clinical approach with behavioural economics and gamification. Sidekick is currently delivering industry-leading retention and clinical impact on health outcomes including weight, cardiovascular fitness, blood glucose, fatigue, quality of life and medication adherence. The result of its patient-centric digital care platform is scalability across a wide range of chronic illnesses. When combined with traditional treatments, the overall efficacy is greatly increased. It achieves this by developing and delivering its therapeutics with digital technology, addressing the same endpoints as traditional treatments such as small molecule drugs and biologics, except with the added benefit of giving people the chance to be actively involved in their own treatment. Sidekick is a digital therapeutics innovator bringing healthcare into people’s everyday lives, empowering them to gain control of their health. Novator Ventures’ general partner and Founder, Birgir Mar Ragnarsson, will join Sidekick’s board on top of this news. This round has thus far gone down as Iceland’s biggest round in 2022, according to Dealroom, and was led by London-based VC Novator Ventures beside Wellington Partners, Asabys Partners and Frumtak Ventures, as well as a US-based strategic investor yet to be revealed. Digital therapeutics are next-gen therapeutics designed to prevent, treat and help people manage a wide range of medical disorders or diseases. Sidekick is a firm on a mission to develop and deliver effective & personalised digital therapeutics that prevent suffering and add quality to millions of lives globally. 9.Following the closing of the company’s oversubscribed $20M Series A in 2020, Sidekick has today announced it has raised $55M in its Series B. The Note 7 even made our list of epic tech fails. Samsung recalled all Note 7s and sent out fireproof bags for customers to use for returns. Though the overheating issues affected only a small percentage of phones, the FAA banned these phones from all flights. Samsung released software updates to limit battery charge and recalled the units to replace their batteries, but those also caught fire. This was due to a battery defect that caused short-circuiting. Note 7 users were reporting that their phones were overheating and catching fire. The phone proved popular upon launch and sold well. It featured a 5.7-inch curved OLED display, 12-megapixel rear camera and an iris recognition system for unlocking the phone. Note 7 was Samsung’s first phone to pack a USB-C connector. The Galaxy Note 7 launched in August 2016 and was pulled off the market two months later. Samsung popularized the phablet with its Galaxy Note series, which had a 10-year run that ended in 2021.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |